Apheresis: What Should a Clinician Know?

Effect of Lipoprotein Apheresis on Progression of Carotid Intima-Media Thickness in Patients with Severe Hypercholesterolemia

(2022) Maya S. Safarova et al.   AMERICAN JOURNAL OF CARDIOLOGY

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

(2021) Henry N Ginsberg et al.   EUROPEAN HEART JOURNAL

Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a)

(2019) Elisa Waldmann et al.   PATHOLOGY

Current Role of Lipoprotein Apheresis

(2019) Gilbert Thompson et al.   Current Atherosclerosis Reports

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Lipoprotein Apheresis for Lipoprotein(a) and Cardiovascular Disease

(2019) Patrick M. Moriarty et al.   Journal of Clinical Lipidology

Reduced incidence of cardiovascular events in hyper-Lp(a) patients on lipoprotein apheresis. The G.I.L.A. (Gruppo Interdisciplinare Aferesi Lipoproteica) pilot study

(2018) Federico Bigazzi et al.   TRANSFUSION AND APHERESIS SCIENCE

From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients

(2018) Maria G Zenti et al.   European Journal of Preventive Cardiology

Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomized controlled cross-over trial

(2017) Tina Z. Khan et al.   EUROPEAN HEART JOURNAL

Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial

(2016) Patrick M. Moriarty et al.   EUROPEAN HEART JOURNAL

Lipoprotein apheresis to treat elevated lipoprotein (a)

(2016) Elisa Waldmann et al.   JOURNAL OF LIPID RESEARCH

Does Regular Lipid Apheresis in Patients With Isolated Elevated Lipoprotein(a) Levels Reduce the Incidence of Cardiovascular Events?

(2013) Adrian Rosada et al.   ARTIFICIAL ORGANS

Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography

(2013) Maya S. Safarova et al.   ATHEROSCLEROSIS SUPPLEMENTS

Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease

(2013) Josef Leebmann et al.   CIRCULATION

Lipid apheresis, indications, and principles

(2011) Jeffrey L. Winters   JOURNAL OF CLINICAL APHERESIS

Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

(2011) Anne C. Goldberg et al.   Journal of Clinical Lipidology

Immunosorbent for Selective Removal of Lipoprotein (a) from Human Plasma: In Vitro Study

(2010) Sergei N. Pokrovsky et al.   ARTIFICIAL ORGANS

Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe

(2010) Gilbert R Thompson et al.   CURRENT OPINION IN LIPIDOLOGY

Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction

(2009) Pia R. Kamstrup   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Recommendations for the use of LDL apheresis

(2008) G.R. Thompson   ATHEROSCLEROSIS